TFH lymphomas: The times they aza-changin'? Editorial


Authors: Weinstock, D. M.; Horwitz, S. M.
Title: TFH lymphomas: The times they aza-changin'?
Keywords: cancer survival; treatment outcome; prednisone; cancer recurrence; doxorubicin; note; disease free survival; nausea; vomiting; cyclophosphamide; vincristine; cancer regression; maximum tolerated dose; drug dose increase; romidepsin; cytopenia; azacitidine; phase 2 clinical trial (topic); phase 1 clinical trial (topic); anaplastic large cell lymphoma; angioimmunoblastic t cell lymphoma; human; priority journal
Journal Title: Blood
Volume: 134
Issue: 17
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2019-10-24
Start Page: 1364
End Page: 1365
Language: English
DOI: 10.1182/blood.2019002806
PUBMED: 31698426
PROVIDER: scopus
PMCID: PMC6839955
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz